1 / 7

Sleep Disorder Market

Sleep Disorder Market

IRFAN13
Télécharger la présentation

Sleep Disorder Market

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Sleep Disorder Market Analysis, Revenue, Price, Market Share, Growth Rate, Forecast to 2027 © 2022 Global Market Insights, Inc. USA. All Rights Reserved www.gminsights.com

  2. Global Sleep Disorder Market • The sleep disorder market is speculated to attain a substantial valuation by 2027 owing to growing geriatric population around the world. In addition, increasing incidences of several lifestyle diseases like diabetes and obesity are set to augment industry uptake over the forthcoming years. • According to a 2021 study published by Elsevier Public Health Emergency Collection, the Covid-19 pandemic has been shown to cause various sleep dysfunctions, including disrupted circadian rhythm, insomnia, and decreased sleep quality among the affected as well as the general population. The mounting prevalence of sleep disorders caused due to the outbreak has prompted healthcare companies to undertake extensive R&D activities, which has boosted market growth in recent years. • To access a sample copy or view the market report in detail along with the table of • contents, please click the link below: https://www.gminsights.com/request-sample/detail/5172 • Notably, industry participants have been implementing lucrative initiatives to gain a competitive edge in the evolving marketplaces, which has positively impacted the overall business scenario. For instance, in June 2021, Cadwell Industries,. © 2022 Global Market Insights, Inc. USA. All Rights Reserved www.gminsights.com

  3. Continue:- • According to the deal, Cadwell has integrated EnsoData'sEnsoSleep AI solution to its Easy III PSG software platform, which is intended to significantly reduce the burden of manual analysis on sleep clinicians, thereby giving them more time to focus on the treatment procedures. • To cite another instance, in December 2019, Eisai, Co., Ltd., received the U.S. Food and Drug Administration (FDA) approval for its novel orexin receptor antagonist, dubbed DAYVIGOTM (Lemborexant). The latest lemborexant drug has been approved for the treatment of insomnia in adults, which is characterized by problems with sleep maintenance or sleep onset. • Browse key industry insights spread across 246 pages with 414 market data tables & 13 figures & charts from the report, “Sleep Disorder Market Size By Disorder Type (Sleep Apnea {Obstructive Sleep Apnea, Central Sleep Apnea, Complex Sleep Apnea}, Insomnia, Restless Legs Syndrome (RLS), Narcolepsy), By Product (Diagnostics {Actigraphy Systems Polysomnography {PSG} Device, Respiratory Polygraph, Sleep Screening Devices, Home Sleep Tests}, Therapeutics {Cognitive Behavioral Therapy, Therapeutic Devices [Airway Clearance System, Adaptive Servo-ventilation (ASV), Positive Airway Pressure (PAP) Devices, Oral Appliances, Oxygen Devices], Medication Therapy [Benzodiazepines, Dual Orexin Receptor Antagonists, Melatonin Receptor Agonists, © 2022 Global Market Insights, Inc. USA. All Rights Reserved www.gminsights.com

  4. 360° Industry Analysis • https://www.gminsights.com/industry-analysis/sleep-disorder-market • The sleep disorder market has been segregated on the basis of product, disorder type, and region. • With respect to disorder type, the market has further been bifurcated into narcolepsy, sleep apnea, restless legs syndrome, insomnia, and others. • The narcolepsy sub-segment accounted for a market share of nearly 8% in 2020 and is projected to grow at a solid pace over the forecast timeline. Increase in the number of diagnoses and treatments for narcolepsy is estimated to drive segmental expansion over the forthcoming years. • In terms of product, the sleep disorder market has been categorized into therapeutics and diagnostics. The diagnostics sub-segment is speculated to attain a substantial valuation by 2027, expanding at a CAGR of approximately 6.9% over the assessment period. Growing awareness regarding sleep disorders would escalate the demand for sleep disorder diagnostics, which is likely to support market development over the analysis timeframe. © 2022 Global Market Insights, Inc. USA. All Rights Reserved www.gminsights.com

  5. Chapter 2   Executive Summary • 2.1    Sleep disorder industry 360° synopsis, 2016 – 2027 • 2.1.1    Business trends • 2.1.2    Disorder type trends • 2.1.3    Product trends • 2.1.4    Regional trends • Browse complete table of content of this report@ https://www.gminsights.com/toc/detail/sleep-disorder-market © 2022 Global Market Insights, Inc. USA. All Rights Reserved www.gminsights.com

  6. Market Players: • Astellas Pharma Inc, • Cadwell Laboratories Inc, • Cardinal Health, • Compumedics Limited, • Eisai Co Ltd, • Evotec AG, • Browse Complete Summary of this report @ https://www.gminsights.com/industry-analysis/sleep-disorder-market © 2022 Global Market Insights, Inc. USA. All Rights Reserved www.gminsights.com

  7. Stay In Touch You can visit us at: www.gminsights.com Thank You…! © 2022 Global Market Insights, Inc. USA. All Rights Reserved www.gminsights.com

More Related